# Cadence Neuroscience: Medical devices, Redmond, United States > Cadence Neuroscience: Cadence Neuroscience is a medical device company based in Redmond, Washington, founded in 2017. Based in Redmond, United States. Source: https://millionrounds.com/startup/cadence-neuroscience (Millionrounds; every figure on the page links to its filing or article) United States · [Medical devices startup](https://millionrounds.com/companies) # Cadence Neuroscience Cadence Neuroscience is a medical device company based in Redmond, Washington, founded in 2017. Email Funding reported Last round: Series B Medical devices Redmond, United States Follow Cadence Neuroscience and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fcadence-neuroscience) Company summary - **Founded:** 2018 8 years old - **Team:** 20 11 to 50 people - **Funding reported:** $41M in dollars - **Last round:** Series B Feb 2023 How sure we are - ✓ **Listed** We know it exists and what it does - 2 **Funding reported** A company dataset reports a raise - 3 **Observed** A filing or a dated announcement confirms a round No round for Cadence Neuroscience has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology) ## About Cadence Neuroscience Cadence Neuroscience is a medical device company based in Redmond, Washington, founded in 2017. The company focuses on developing personalized neuromodulation therapies for drug-resistant epilepsy and other neurological disorders, particularly for pediatric and adult patients. Their primary product is the Biomarker Targeted Stimulation (BTS) device, which detects specific brain signals associated with seizures and delivers targeted electrical stimulation to interrupt seizure progression. The BTS device aims to provide a less invasive alternative to traditional surgical treatments, offering personalized, adaptive therapy based on each patient's unique brain activity. Cadence Neuroscience is currently conducting pivotal clinical trials to support regulatory approval from the U.S. Food and Drug Administration (FDA). With a mission to transform patient care, the company seeks to enable individuals to live seizure-free lives through innovative treatment options. ## What company datasets say Cadence Neuroscience raised Funding, as reported Reported in all **$41M** in dollars Rounds **3** Last round **Series B** Last round size **$6.0M** Last round date **Feb 2023** Investors listed **8** SEC Form D **$29M sold, 3 filings, last Feb 2023** ## Founders and team From Cadence Neuroscience's own website and the SEC filings it signed: 2 founders, 11 on the team. **Doug Sheffield** Chief Scientific Officer, Founder **Kent Leyde** Chief Technology Officer, Founder *Named on its 2023 Form D* - **Chris Cronin** Chief Executive Officer - **Eric Peterson** VP of Quality and Operations - **Dan Pederson** Director of Engineering - **David Himes** Director of Clinical Affairs - **Erik Anderson** Senior Electrical Engineer - **Glen Baker** Senior Software Architect - **Linda Alcorn** Quality Systems Manager - **Mike Bland** Director of Engineering - **Mike Marx** Senior Software Quality Engineer - **Tina Yerges** Director, Business and Finance - **Warren Douglas Sheffield** Executive Officer i On the board, as filed i *Gerry Douglas Brunk* *John Douglas Harris* *Kevin Douglas Chu* ## On 3 portfolio pages Investors who name them - [For Good Ventures](https://millionrounds.com/fund/for-good-ventures) - [Jazz Venture Partners](https://millionrounds.com/fund/jazz-venture-partners) - [Iaso Ventures](https://millionrounds.com/fund/iaso-ventures) Each firm lists Cadence Neuroscience on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source. ## The company, in detail What they build Known for health care digital health therapy personalization drug-resistant focal epilepsy enterprises personalized therapy medical equipment manufacturing information technology & services enterprise software hospital & health care personalized epilepsy therapy biomarker targeting stimulation health biotechnology electrical current delivery clinical trial stimulation Built with from their website Google Workspace Google Cloud Hosting Google Meet Microsoft 365 Enom Google Search Console Gmail - **Sector:** Medical devices - **Industry code:** NAICS 339112, SIC 3845, 3841 - **Region:** Washington - **Revenue:** $4.0M a year, as listed - **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/cadence-neuroscience) ## Medical devices in United States Startups like it - [**Precision Neuroscience** New York · founded 2021 *Raised*](https://millionrounds.com/company/precision-neuroscience) - [**Synchron** New York · founded 2016 *Raised*](https://millionrounds.com/company/synchron) - [**SetPoint Medical** Santa Clarita · founded 2007 *Raised*](https://millionrounds.com/company/setpoint-medical) - [**Apreo Health** Menlo Park *Raised*](https://millionrounds.com/company/apreo-health) - [**Cleerly** Denver · founded 2017 *Raised*](https://millionrounds.com/company/cleerly) - [**CereVasc** Boston · founded 2013 *Raised*](https://millionrounds.com/company/cerevasc) - [**Galvanize** Redwood City · founded 2015 *Raised*](https://millionrounds.com/company/galvanize) - [**Endovascular Engineering, Inc. (E2)** Startup *Raised*](https://millionrounds.com/company/endovascular-engineering-inc-e2) ## Is this your company? Add your raise, your deck and your story, and put Cadence Neuroscience in front of investors. Or tell us what we have wrong. [List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)